Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced Novasign and Repligen have entered into a strategic partnership to develop ...

An international initiative will transform biologics and drug manufacturing through AI-driven multiplatform integration. The AI-optimised BALANCE (Bioreactor Automation for Learning and Adaptive ...

The most powerful applications of artificial intelligence (AI) aren't emerging from speculative start-ups but from within America's most established industries. While Wall Street chases tech stocks ...